Gyldenpharma
1 known investors
Gylden Pharma is a biotech company developing microneedle patch platforms that use the biology of the dermis for systemic drug delivery and immune activation. Its lead asset, Zograine, is a zolmitriptan titanium microneedle patch for acute migraine, and its pipeline includes COVID, dengue, chikungunya and Ebola vaccines plus an oncology program.
Investors · 1
Frequently asked questions
- What does Gyldenpharma do?
- Gylden Pharma is a biotech company developing microneedle patch platforms that use the biology of the dermis for systemic drug delivery and immune activation. Its lead asset, Zograine, is a zolmitriptan titanium microneedle patch for acute migraine, and its pipeline includes COVID, dengue, chikungunya and Ebola vaccines plus an oncology program.
- Who are Gyldenpharma's investors?
- Gyldenpharma's investors include Vickers Venture Partners.